Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Regional disparities in interferon therapy for chronic hepatitis C in Japan: a nationwide retrospective cohort study.

BMC public health - 19 Jun 2015

Masaki Naohiko, Yamagiwa Yoko, Shimbo Takuro, Murata Kazumoto, Korenaga Masaaki, Kanto Tatsuya, Mizokami Masashi

Abstract excerpt

BACKGROUND: Many patients with chronic hepatitis C have been treated with interferon (IFN) therapy in Japan, especially after the introduction of subsidies for medical expenses in 2008. However, its performance and outcome have never been evaluated. Therefore, a nationwide, mail-based, retrospective cohort study was conducted. METHODS: Regional disparities in the demographic features, treatment performance, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Administration Schedule
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Healthcare Disparities

Share to Hepatitis C, Chronic

Share to Immunotherapy

Share to Interferon-alpha

Share to Polyethylene Glycols

Share to Ribavirin

Source

Open in PubMed Open full text

Identifiers

PMID: 26088426
DOI: 10.1186/s12889-015-1891-2
PMCID: PMC4474553

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Regional disparities in interferon therapy for chronic hepatitis C in Japan: a nationwide retrospective cohort study.PMID 26088426Read ↗

Regional Differences in Hepatitis C Treatment with Peginterferon and Ribavirin in Japan in Both Genotype 1 and Genotype 2: A Retrospective Cohort Study.Semantic proximity Read ↗

The nationwide distribution and trends of hepatitis C virus genotypes in mainland China.Semantic proximity Read ↗

Current treatment status and barriers for patients with chronic HCV infection in mainland China: A national multicenter cross-sectional survey in 56 hospitals.Semantic proximity Read ↗

The genotype distribution of hepatitis C in southeastern Taiwan: Clinical characteristics, racial difference, and therapeutic response.Semantic proximity Read ↗

Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences.Semantic proximity Read ↗

Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver diseases: a multi-institution analysis.Semantic proximity Read ↗

Treatment rate and factors related to interferon-based treatment initiation for chronic hepatitis C in South Korea.Semantic proximity Read ↗

Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in JapanSemantic proximity Read ↗

The impact of ethnicity on hepatitis C virus treatment decisions and outcomes.Semantic proximity Read ↗

Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan.Semantic proximity Read ↗

Sociodemographic Disparities in Hepatitis C Care Utilization and Testing in the United States: A Nationwide Survey AnalysisSemantic proximity Read ↗

Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.